A phase <scp>III</scp> randomized trial evaluating the quality of life impact of a tailored versus systematic use of defunctioning ileostomy following total mesorectal excision for rectal cancer—<scp>GRECCAR</scp> 17 trial protocol
- DOI
- 10.1111/codi.16428
- Published
- 2022-12-29
- Container
- Colorectal Disease
- Publisher
- Wiley
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1111/codi.16428,
title = {A phase <scp>III</scp> randomized trial evaluating the quality of life impact of a tailored versus systematic use of defunctioning ileostomy following total mesorectal excision for rectal cancer—<scp>GRECCAR</scp> 17 trial protocol},
author = {Quentin Denost and Dienabou Sylla and Christina Fleming and Helene Maillou‐Martinaud and Nathalie Preaubert‐Hayes and Antoine Benard and Unknown},
year = {2022},
journal = {Colorectal Disease},
doi = {10.1111/codi.16428},
url = {https://doi.org/10.1111/codi.16428}
}RIS
TY - JOUR TI - A phase <scp>III</scp> randomized trial evaluating the quality of life impact of a tailored versus systematic use of defunctioning ileostomy following total mesorectal excision for rectal cancer—<scp>GRECCAR</scp> 17 trial protocol AU - Quentin Denost AU - Dienabou Sylla AU - Christina Fleming AU - Helene Maillou‐Martinaud AU - Nathalie Preaubert‐Hayes AU - Antoine Benard AU - Unknown PY - 2022 JO - Colorectal Disease DO - 10.1111/codi.16428 UR - https://doi.org/10.1111/codi.16428 ER -
APA
Denost, Q., Sylla, D., Fleming, C., Maillou‐Martinaud, H., Preaubert‐Hayes, N., Benard, A., & Unknown (2022). A phase <scp>III</scp> randomized trial evaluating the quality of life impact of a tailored versus systematic use of defunctioning ileostomy following total mesorectal excision for rectal cancer—<scp>GRECCAR</scp> 17 trial protocol. Colorectal Disease. https://doi.org/10.1111/codi.16428
Source records
- crossref · retrieved 2026-09-25T10:32:07.549Z